Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01, its lead clinical-stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. ACP-01 is in a Phase 2 clinical trial in Canada and the United States. Its technology includes methods for collecting the synergetic cell population and manufacturing a personalized regenerative therapy that can be administered to a patient within seven days of the initial cell collection. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd. and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Comment by theguru1on Jan 22, 2010 10:03am
126 Views
Post# 16707446

RE: RE: RE: Q4 growth?

RE: RE: RE: Q4 growth?You must be talking about "we" as the company, because you can't possibly be talking about "we" as the shareholders! One of the worst performing stocks of 2009.

Yup. This company had one of the worst years for shareholder ever. That being said if the company just opened today with a 1 dollar share price would you be a buyer? I look at there products, market share, no debt,  penetration into new countries, and think this company has a good shot at making it.  Down side in the short term to upside long term at these prices looks like a worthy gamble. (Its always a gamble)  I'm betting for a nice recovery in 2010 and a 100% increase in stock price with the company only meeting a 10 % increase in revenue. If they can pull off a 15-20% increase the stock maybe able to run higher. This should be attainable when comparing to such a dismal year in 2009.
Good Luck,
IMHO
Bullboard Posts